Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy

Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
Human Molecular Genetics (Impact Factor: 6.39). 12/2010; 19(23):4573-86. DOI: 10.1093/hmg/ddq385
Source: PubMed


A major function of proteasomes and macroautophagy is to eliminate misfolded potentially toxic proteins. Mammalian proteasomes, however, cannot cleave polyglutamine (polyQ) sequences and seem to release polyQ-rich peptides. Puromycin-sensitive aminopeptidase (PSA) is the only cytosolic enzyme able to digest polyQ sequences. We tested whether PSA can protect against accumulation of polyQ fragments. In cultured cells, Drosophila and mouse muscles, PSA inhibition or knockdown increased aggregate content and toxicity of polyQ-expanded huntingtin exon 1. Conversely, PSA overexpression decreased aggregate content and toxicity. PSA inhibition also increased the levels of polyQ-expanded ataxin-3 as well as mutant α-synuclein and superoxide dismutase 1. These protective effects result from an unexpected ability of PSA to enhance macroautophagy. PSA overexpression increased, and PSA knockdown or inhibition reduced microtubule-associated protein 1 light chain 3-II (LC3-II) levels and the amount of protein degradation sensitive to inhibitors of lysosomal function and autophagy. Thus, by promoting autophagic protein clearance, PSA helps protect against accumulation of aggregation-prone proteins and proteotoxicity.

Download full-text


Available from: Raphael Hourez
  • Source
    • "This hydrolytic activity of ERAPs is essential for generating peptides with appropriate size for binding to major histocompatibility complex type I, which enhances antigen presentation (Kloetzel and Ossendorp, 2004; Saveanu et al., 2009; Van Endert, 2011; Weimershaus et al., 2013). PSA activity of proteasome is the main responsible for the degradation of polyQ, which are highly toxic and associated with neurodegenerative diseases when accumulated (Bhutani et al., 2007; Menzies et al., 2010). Increased PSA activity found in low density microsomal fraction (proteasome-containing fraction) (Brooks et al., 2000) should affect the immune system in obese. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study checked the existence of a diverse array of aminopeptidase (AP) enzymes in high (HDM) and low (LDM) density microsomal and plasma membrane (MF) fractions from adipocytes of control, monosodium glutamate obese and food deprived rats. Gene expression was detected for ArgAP, AspAP, MetAP, and two AlaAP (APM and PSA). APM and PSA had the highest catalytic efficiency, whereas AspAP the highest affinity. Subcellular distribution of AP activities depended on metabolic status. Comparing catalytic levels, AspAP in HDM, LDM and MF was absent in obese and control under food deprivation; PSA in LDM was 3.5-times higher in obese than in normally fed control and control and obese under food deprivation; MetAP in MF was 4.5-times higher in obese than in food deprived obese. Data show new AP enzymes genetically expressed in subcellular compartments of adipocytes, three of them with altered catalytic levels that respond to whole-body energetic demands. Copyright © 2015. Published by Elsevier Ireland Ltd.
    Full-text · Article · Aug 2015 · Molecular and Cellular Endocrinology
  • Source
    • "Finally, as we have shown that EGb 761 reduces the amount of polyQ aggregates we tested the possible involvement of autophagy in the clearance of polyQ aggregates [42]. Therefore, we analyzed the general autophagosomal flux in HEK293 cells expressing htt_Q103 treated with EGb 761 or vehicle (Figures 4(d) and 4(e)), followed by a challenge with 1 μM lysosome inhibitor bafilomycin A1. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The standardized Ginkgo biloba extract EGb 761 has well-described antioxidative activities and effects on different cytoprotective signaling pathways. Consequently, a potential use of EGb 761 in neurodegenerative diseases has been proposed. A common characteristic feature of a variety of such disorders is the pathologic formation of protein aggregates, suggesting a crucial role for protein homeostasis. In this study, we show that EGb 761 increased the catalytic activity of the proteasome and enhanced protein degradation in cultured cells. We further investigated this effect in a cellular model of Huntington's disease (HD) by employing cells expressing pathologic variants of a polyglutamine protein (polyQ protein). We show that EGb 761 affected these cells by (i) increasing proteasome activity and (ii) inducing a more efficient degradation of aggregation-prone proteins. These results demonstrate a novel activity of EGb 761 on protein aggregates by enhancing proteasomal protein degradation, suggesting a therapeutic use in neurodegenerative disorders with a disturbed protein homeostasis.
    Full-text · Article · Jun 2014 · Evidence-based Complementary and Alternative Medicine
  • Source
    • "As a consequence, polyQ peptides that have a high propensity to aggregate into fibrillar assemblies (Wetzel 2012) are released from the proteasome during the degradation of huntingtin (Holmberg et al. 2004; Venkatraman et al. 2004) and other polyQ proteins. That free polyQ peptides are not readily detected in cells can be due to their immediate capture by DNAJB6-like chaperones and subsequent degradation by peptidases or autophagy (Menzies et al. 2010). If such processing fails, polyQ peptides would, however, become enriched and immediately seed aggregation into both main and side chain hydrogen-bonded fibrillar structures (Berryman et al. 2009; Streets et al. 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Expanded polyglutamine (polyQ) stretches lead to protein aggregation and severe neurodegenerative diseases. A highly efficient suppressor of polyQ aggregation was identified, the DNAJB6, when molecular chaperones from the HSPH, HSPA, and DNAJ families were screened for huntingtin exon 1 aggregation in cells (Hageman et al. in Mol Cell 37(3):355–369, 2010). Furthermore, also aggregation of polyQ peptides expressed in cells was recently found to be efficiently suppressed by co-expression of DNAJB6 (Gillis et al. in J Biol Chem 288:17225–17237, 2013). These suppression effects can be due to an indirect effect of DNAJB6 on other cellular components or to a direct interaction between DNAJB6 and polyQ peptides that may depend on other cellular components. Here, we have purified the DNAJB6 protein to investigate the suppression mechanism. The purified DNAJB6 protein formed large heterogeneous oligomers, in contrast to the more canonical family member DNAJB1 which is dimeric. Purified DNAJB6 protein, at substoichiometric molar ratios, efficiently suppressed fibrillation of polyQ peptides with 45°Q in a thioflavin T fibrillation. No suppression was obtained with DNAJB1, but with the closest homologue to DNAJB6, DNAJB8. The suppression effect was independent of HSPA1 and ATP. These data, based on purified proteins and controlled fibrillation in vitro, strongly suggest that the fibrillation suppression is due to a direct protein–protein interaction between the polyQ peptides and DNAJB6 and that the DNAJB6 has unique fibrillation suppression properties lacking in DNAJB1. Together, the data obtained in cells and in vitro support the view that DNAJB6 is a peptide-binding chaperone that can interact with polyQ peptides that are incompletely degraded by and released from the proteasome. Electronic supplementary material The online version of this article (doi:10.1007/s12192-013-0448-5) contains supplementary material, which is available to authorized users.
    Full-text · Article · Aug 2013 · Cell Stress and Chaperones
Show more